This transaction marks the third investment from its latest fund, Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.
Founded in 2009, Viseven has expanded to over 30 countries, with development hubs in Ukraine, as well as Argentina, Estonia, India, Poland and North America. Known as an innovator, the Company has been constantly launching new products, including a digital content factory, cloud-based CRM and CLM suites powered by no-code functionality and enabled by AI tools, for an end-to-end digital marketing platform. Led by Nataliya Andreychuk (CEO), and co-founders Vyacheslav Vasylenko (COO) and Roman Vasylenko (CTO), Viseven services over 50 pharma and life sciences customers, and many of top-20 global companies, including Abbott, AbbVie, Amgen, Bayer, Biogen, Ipsen, Lilly, Novo Nordisk, Servier Laboratories and others. Typical for Horizon Capital investees, the business has strong fundamentals, is profitable and has grown at a consistently high rate, more than tripling revenues since 2019.
Lenna Koszarny, Founding Partner and CEO at Horizon Capital, said: “I am delighted to announce Horizon Capital’s investment in another global tech champion out of Ukraine, in a sign of enduring resilience for our Region. Nataliya is a truly inspiring leader and we are privileged to be backing the Viseven team with growth capital in this next chapter of their high-growth journey. As a 2X Flagship Fund, promoting gender-smart investing, we are particularly proud to be backing a woman-founded and led technology company, making this investment even more meaningful.”
Nataliya Andreychuk, Co-founder and CEO at Viseven, said: “We are delighted to welcome Horizon Capital as a value-add investor and look forward to putting their capital to good work in scaling up investments in our technology platform at a time when AI is creating enormous opportunities for our industry. We are grateful to our precious customers for their trust over the years and are confident that they will soon experience first-hand the benefits of this investment.”
Vasile Tofan, Senior Partner at Horizon Capital, added: “Viseven is yet another compelling example of the world-class technology coming out of Ukraine. We have known the Company for over five years and have high regard for its vertical software strategy, leveraged by access to some of the best engineering talent in the world. The combination of strong unit economics, high growth and superb customer feedback, position Viseven well for enduring success in the marketplace.”
About Viseven
Viseven is a leading global provider of digital marketing solutions and services for the pharma and life sciences industry, with a mission of saving lives by improving communication. Established in 2009 Viseven grew to over 700 professionals, servicing over 50 global customers, including many of the top 20 pharma and life sciences companies, from offices in Ukraine, as well as Argentina, Estonia, India, Poland and North America. The Company has been contributing over the years to nurturing the Ukrainian tech ecosystem through its Viseven IT Academy, a free corporate university focused on technology roles, with over 1,100 graduates to date. The Company counts AVentures Capital and Horizon Capital among its investors and remains founders’ led.
About Horizon Capital
Horizon Capital is the leading private equity firm in Emerging Europe with over $1.5 billion in AUM from investors with a capital base exceeding $630 billion, raising circa $0.8 billion in growth capital in just over five years, including $328 million HCGF IV. The firm’s investment strategy focuses on backing visionary entrepreneurs leading fast-growing, primarily tech and export-oriented businesses in Ukraine and Moldova. Horizon Capital-managed funds have invested in over 170 companies employing over 80,000 people.
